Recognition of different subsets of alloreactive T cells by activation-induced markers
Alloreactive T-cells can be visualized using activation-induced markers (AIMs) including CD69, CD134, CD137 and CD154. Whether these AIMs recognize similar subsets of alloreactive T-cells is largely unknown. AIM-expressing alloreactive CD4+ T cells were analyzed in detail for phenotype by dissecting different T-cell subsets using antibodies directed to CCR7 and CD45RA. Moreover, detailed functional analysis was performed by determining proportions of cytokine producing cells within AIM-expressing CD4+ T cells using multiparameter flowcytometry. CD154 was predominantly expressed by naïve and central-memory alloreactive CD4+ T cells, CD134 by central-memory alloreactive CD4+ T cells and CD137 by CD4+ alloreactive memory T cells. Alloreactive CD8+ T cells could only be recognized by CD137 expression. The majority of alloreactive CD4+ T cells were single AIM-positive (72 %) and co-expression of all AIMs was infrequent. Polyclonal stimulation with anti-CD3/anti-CD28 resulted in a high frequency of CD4+ T cells co-expressing AIMs which was a dose-dependent phenomenon. Alloreactive memory CD4+ T cells expressing >1 AIM showed the highest proportion of polyfunctional cells. Allogeneic stimulation of sorted naïve CD4+ T cells yielded a population of proliferating T cells, progressing to effector-memory T cells expressing >1 AIM. In conclusion, different AIMs are preferentially expressed by different subsets of circulating alloreactive CD4+ T cells and expression of AIMs is determined by proliferation/differentiation and strength of the T cell receptor (TCR)-stimulation.
Authors
- Elke Valk
- Michiel G.H. Betjes (ORCID: https://orcid.org/0000-0001-9435-6208)
- Nicolle H. R. Litjens (ORCID: https://orcid.org/0000-0003-2504-1805)
- Amy C. J. van der List (ORCID: https://orcid.org/0000-0002-4163-2317)
- Guillaume Smits (ORCID: https://orcid.org/0000-0003-2845-6758)
- Mariska Klepper
Institutions
- Erasmus MC (NL)
- Erasmus MC Cancer Institute (NL)
Publication Details
- Journal
- Transplant Immunology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1016/j.trim.2025.102227
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00